This week, a presentation of CureSight™ was held at the ophthalmology department of the Santo António University Hospital Centre (in OPorto), attended by the specialist doctors who work there.
CureSight™ is a revolutionary device that offers modern and highly effective treatment for amblyopia in children aged between 4 and 9, without the need for eye patches.
With eye tracking technology and real-time image processing, CureSight™ selectively blurs the vision of the dominant eye, encouraging the weaker eye to work and improve visual acuity. All this happens in an easy and fun way, while the child watches their favourite programmes.
CureSight™ is the new solution for treating amblyopia in a more comfortable and effective way.
Events
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
goldfarma © 2025 all rights reserved
